MacroGenics, Inc. Common Stock (NASDAQ: MGNX) last traded at $3.35, down 2.05% on the session. The quote above updates while this page is open; the figures below are drawn from MacroGenics, Inc. Common Stock’s own filings and are restated only when a new one is published.
MacroGenics, Inc. Common Stock trades on NASDAQ under the ticker MGNX. Its market capitalisation is $213.40 million.
Valuation measures for MacroGenics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $213.40M |
|---|---|
| Enterprise value | $402.02M |
| Price / sales | 1.27 |
| Price / book | 4.98 |
| Beta | 0.97 |
Trailing-twelve-month figures tagged in MacroGenics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $167.67M |
|---|---|
| Net income (TTM) | -$14.59M |
| EPS (TTM) | -$0.230 |
| Operating margin | -20.45% |
| Return on equity | -34.04% |
| Cash | $113.91M |
Range and volume for MGNX over the past 52 weeks.
| 52-week high | $5.08 |
|---|---|
| 52-week low | $1.29 |
| Volume | 30.2K |
| Average volume | 595.3K |
| Previous close | $3.42 |
Invest a chosen dollar amount in MacroGenics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MGNX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.